{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:15:23Z","timestamp":1790889323128,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/ncpendmet0637","type":"journal-article","created":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T16:57:43Z","timestamp":1190653063000},"page":"688-695","source":"Crossref","is-referenced-by-count":107,"title":["The reproductive phenotype in polycystic ovary syndrome"],"prefix":"10.1038","volume":"3","author":[{"given":"R Jeffrey","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet0637_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R  et al. (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89: 453\u2013462","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","volume":"30","author":"GS Conway","year":"1989","unstructured":"Conway GS  et al. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 30: 459\u2013470","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet0637_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","volume":"59","author":"RS Legro","year":"2004","unstructured":"Legro RS  et al. (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59: 141\u2013154","journal-title":"Obstet Gynecol Surv"},{"key":"BFncpendmet0637_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","volume":"167","author":"E Carmina","year":"1992","unstructured":"Carmina E  et al. (1992) Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167: 1807\u20131812","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpendmet0637_CR5","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/humrep\/deg440","volume":"18","author":"E Carmina","year":"2003","unstructured":"Carmina E  et al. (2003) Differences in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 18: 2289\u20132293","journal-title":"Hum Reprod"},{"key":"BFncpendmet0637_CR6","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19\u201325","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"BFncpendmet0637_CR7","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41\u201347","DOI":"10.1093\/humrep\/deh098"},{"key":"BFncpendmet0637_CR8","first-page":"111","volume-title":"Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome","author":"GF Erickson","year":"1992","unstructured":"Erickson GF (1992) Folliculogenesis in polycystic ovary syndrome. In Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome, 111\u2013128 (Eds Dunaif A  et al.) Cambridge, MA: Blackwell Scientific Publishers"},{"key":"BFncpendmet0637_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","volume":"37","author":"P Hughesdon","year":"1982","unstructured":"Hughesdon P (1982) Morphology and morphogenesis of the stein-leventhal ovary and of so-called \u201chyperthecosis\u201d. Obstet Gynecol Surv 37: 59\u201377","journal-title":"Obstet Gynecol Surv"},{"key":"BFncpendmet0637_CR10","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1210\/jc.2004-0643","volume":"89","author":"GA Maciel","year":"2004","unstructured":"Maciel GA  et al. (2004) Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab 89: 5321\u20135327","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","volume":"362","author":"LJ Webber","year":"2003","unstructured":"Webber LJ  et al. (2003) Formation and early development of follicles in the polycystic ovary. Lancet 362: 1017\u20131021","journal-title":"Lancet"},{"key":"BFncpendmet0637_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C  et al. (2004) Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10: 77\u201383","journal-title":"Mol Hum Reprod"},{"key":"BFncpendmet0637_CR13","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1210\/jc.2005-0907","volume":"90","author":"SA Stubbs","year":"2005","unstructured":"Stubbs SA  et al. (2005) Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab 90: 5536\u20135543","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR14","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1210\/jc.2006-2425","volume":"92","author":"DS Wachs","year":"2007","unstructured":"Wachs DS  et al. (2007) Serum anti-mullerian hormone concentrations are not affected by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. J Clin Endocrinol Metab 92: 1871\u20131874","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0015-0282(16)60450-8","volume":"51","author":"GF Erickson","year":"1989","unstructured":"Erickson GF  et al. (1989) Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplasia. Fertil Steril 51: 173\u2013176","journal-title":"Fertil Steril"},{"key":"BFncpendmet0637_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1210\/jcem-59-3-389","volume":"59","author":"A Dunaif","year":"1984","unstructured":"Dunaif A  et al. (1984) The effects of continuous androgen secretion on the hypothalamic-pituitary axis in women: evidence from a luteinized thecoma of the ovary. J Clin Endocrinol Metab 59: 389\u2013393","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR17","first-page":"1328","volume":"79","author":"RB Barnes","year":"1994","unstructured":"Barnes RB  et al. (1994) Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 79: 1328\u20131333","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jcem-62-1-16","volume":"62","author":"W Futterweit","year":"1986","unstructured":"Futterweit W and Deligdisch L (1986) Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 62: 16\u201321","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/jcem-69-1-151","volume":"69","author":"T Spinder","year":"1989","unstructured":"Spinder T  et al. (1989) The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab 69: 151\u2013157","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR20","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/0046-8177(94)90037-X","volume":"25","author":"S Chadha","year":"1994","unstructured":"Chadha S  et al. (1994) Androgen receptor expression in human ovarian and uterine tissue of long term androgen-treated transsexual women. Hum Pathol 25: 1198\u20131204","journal-title":"Hum Pathol"},{"key":"BFncpendmet0637_CR21","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI2081","volume":"101","author":"KA Vendola","year":"1998","unstructured":"Vendola KA  et al. (1998) Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101: 2622\u20132629","journal-title":"J Clin Invest"},{"key":"BFncpendmet0637_CR22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/mend.13.6.0311","volume":"13","author":"VL Nelson","year":"1999","unstructured":"Nelson VL  et al. (1999) Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13: 946\u2013957","journal-title":"Mol Endocrinol"},{"key":"BFncpendmet0637_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2006.01.003","volume":"17","author":"JK Wickenheisser","year":"2006","unstructured":"Wickenheisser JK  et al. (2006) Human ovarian theca cells in culture. Trends Endocrinol Metab 17: 65\u201371","journal-title":"Trends Endocrinol Metab"},{"key":"BFncpendmet0637_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1056\/NEJM198903023200904","volume":"320","author":"RB Barnes","year":"1989","unstructured":"Barnes RB  et al. (1989) Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 320: 559\u2013565","journal-title":"N Engl J Med"},{"key":"BFncpendmet0637_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1210\/er.16.3.322","volume":"16","author":"DA Ehrmann","year":"1995","unstructured":"Ehrmann DA  et al. (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16: 322\u2013353","journal-title":"Endocr Rev"},{"key":"BFncpendmet0637_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","volume":"47","author":"C Gilling-Smith","year":"1997","unstructured":"Gilling-Smith C  et al. (1997) Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol 47: 93\u201399","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet0637_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0015-0282(16)47064-0","volume":"39","author":"RA Lobo","year":"1983","unstructured":"Lobo RA  et al. (1983) Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome. Fertil Steril 39: 674\u2013678","journal-title":"Fertil Steril"},{"key":"BFncpendmet0637_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1210\/jcem-56-5-897","volume":"56","author":"R Chang","year":"1983","unstructured":"Chang R  et al. (1983) Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 56: 897\u2013903","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR29","first-page":"1488","volume":"78","author":"A El-Roeiy","year":"1994","unstructured":"El-Roeiy A  et al. (1994) Expression of the genes encoding the insulin-like growth factors IGF-I and II, the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78: 1488\u20131496","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR30","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1210\/jcem.80.12.8530637","volume":"80","author":"D Willis","year":"1995","unstructured":"Willis D and Franks S (1995) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 80: 3788\u20133790","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0015-0282(16)55675-1","volume":"59","author":"C Bergh","year":"1993","unstructured":"Bergh C  et al. (1993) Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 59: 323\u2013331","journal-title":"Fertil Steril"},{"key":"BFncpendmet0637_CR32","doi-asserted-by":"publisher","first-page":"73S","DOI":"10.1097\/00006250-198409001-00019","volume":"64","author":"RL Barbieri","year":"1984","unstructured":"Barbieri RL  et al. (1984) Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca. Obstet Gynecol 64: 73S\u201380S","journal-title":"Obstet Gynecol"},{"key":"BFncpendmet0637_CR33","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1210\/jcem-62-5-904","volume":"62","author":"RL Barbieri","year":"1986","unstructured":"Barbieri RL  et al. (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62: 904\u2013910","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR34","first-page":"2001","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE  et al. (1998) Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83: 2001\u20132005","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1210\/jcem-64-1-180","volume":"64","author":"JE Nestler","year":"1987","unstructured":"Nestler JE  et al. (1987) The effects of hyperandrogenemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 64: 180\u2013184","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI113864","volume":"83","author":"A Dunaif","year":"1989","unstructured":"Dunaif A and Graf M (1989) Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with polycystic ovary syndrome J Clin Invest 83: 23\u201329","journal-title":"J Clin Invest"},{"key":"BFncpendmet0637_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1210\/jcem-67-3-460","volume":"67","author":"SR Plymate","year":"1988","unstructured":"Plymate SR  et al. (1988) Inhibition of sex hormone-binding globulin production in the human hepatoma (hep g2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67: 460\u2013464","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR38","first-page":"1283","volume":"80","author":"JC Crave","year":"1995","unstructured":"Crave JC  et al. (1995) Differential effects of insulin and insulin-like growth factor I on the production on plasma steroid binding globulins by human hepatoblastoma-derived (hepg2) cells. J Clin Endocrinol Metab 80: 1283\u20131289","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1055\/s-2007-1001725","volume":"26","author":"V Lassmann-Vague","year":"1994","unstructured":"Lassmann-Vague V  et al. (1994) SHBG (sex hormone-binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration. Horm Metab Res 26: 436\u2013437","journal-title":"Horm Metab Res"},{"key":"BFncpendmet0637_CR40","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1210\/jc.2003-030219","volume":"88","author":"P-H Ducluzeau","year":"2003","unstructured":"Ducluzeau P-H  et al. (2003) Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 3626\u20133631","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0021-9150(01)00667-0","volume":"161","author":"G Mingrone","year":"2002","unstructured":"Mingrone G  et al. (2002) Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery. Atherosclerosis 161: 455\u2013462","journal-title":"Atherosclerosis"},{"key":"BFncpendmet0637_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/er.2004-0004","volume":"26","author":"HF Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale HF  et al. (2005) The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26: 251\u2013282","journal-title":"Endocr Rev"},{"key":"BFncpendmet0637_CR43","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jcem-70-4-894","volume":"70","author":"GF Erickson","year":"1990","unstructured":"Erickson GF  et al. (1990) The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab 70: 894\u2013902","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR44","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1210\/jc.2003-030745","volume":"88","author":"MS Coffler","year":"2003","unstructured":"Coffler MS  et al. (2003) Enhanced granulosa cell responsiveness to follicle stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone. J Clin Endocrinol Metab 88: 5624\u20135631","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1046\/j.1365-2265.1996.724545.x","volume":"44","author":"G Almahbobi","year":"1996","unstructured":"Almahbobi G  et al. (1996) Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol 44: 571\u2013580","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet0637_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0303-7207(77)90091-0","volume":"8","author":"A Nimrod","year":"1977","unstructured":"Nimrod A (1977) Studies on the synergistic effect of androgen on the stimulation of progestin secretion by FSH in cultured rat granulosa cells: progesterone metabolism and the effect of androgens. Mol Cell Endocrinol 8: 189\u2013199","journal-title":"Mol Cell Endocrinol"},{"key":"BFncpendmet0637_CR47","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1210\/endo-107-4-1027","volume":"107","author":"S Daniel","year":"1980","unstructured":"Daniel S and Armstrong D (1980) Enhancement of follicle-stimulating hormone-induced aromatase activity by androgens in cultured rat granulosa cells. Endocrinology 107: 1027\u20131033","journal-title":"Endocrinology"},{"key":"BFncpendmet0637_CR48","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1210\/endo-109-4-1303","volume":"109","author":"S Hillier","year":"1981","unstructured":"Hillier S and De Zwart F (1981) Evidence that granulosa cell aromatase induction\/activation by follicle-stimulating hormone is an androgen receptor-regulated process in-vitro. Endocrinology 109: 1303\u20131305","journal-title":"Endocrinology"},{"key":"BFncpendmet0637_CR49","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1210\/endo-119-3-1403","volume":"119","author":"C Harlow","year":"1986","unstructured":"Harlow C  et al. (1986) Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary. Endocrinology 119: 1403\u20131405","journal-title":"Endocrinology"},{"key":"BFncpendmet0637_CR50","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1210\/endo-114-6-1975","volume":"114","author":"SAJ Daniel","year":"1984","unstructured":"Daniel SAJ and Armstrong DT (1984) Site of action of androgens on follicle-stimulating hormone-induced aromatase activity in cultured rat granulosa cells. Endocrinology 114: 1975\u20131982","journal-title":"Endocrinology"},{"key":"BFncpendmet0637_CR51","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1210\/jcem.83.7.4917","volume":"83","author":"SJ Weil","year":"1998","unstructured":"Weil SJ  et al. (1998) Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 83: 2479\u20132485","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR52","first-page":"302","volume":"81","author":"D Willis","year":"1996","unstructured":"Willis D  et al. (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81: 302\u2013309","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR53","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","volume":"90","author":"E Velazquez","year":"1997","unstructured":"Velazquez E  et al. (1997) Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 90: 392\u2013395","journal-title":"Obstet Gynecol"},{"key":"BFncpendmet0637_CR54","first-page":"1626","volume":"86","author":"R Azziz","year":"2001","unstructured":"Azziz R  et al. (2001) Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86: 1626\u20131632","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0015-0282(16)48911-9","volume":"44","author":"J DeFazio","year":"1985","unstructured":"DeFazio J  et al. (1985) Acute ovarian responses to a long-acting agonist of gonadotropin-releasing hormone in ovulatory women and women with polycystic ovarian disease. Fertil Steril 44: 453\u2013459","journal-title":"Fertil Steril"},{"key":"BFncpendmet0637_CR56","first-page":"423","volume":"83","author":"M Van Der Meer","year":"1998","unstructured":"Van Der Meer M  et al. (1998) Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. J Clin Endocrinol Metab 83: 423\u2013426","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR57","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI108400","volume":"57","author":"R Rebar","year":"1976","unstructured":"Rebar R  et al. (1976) Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 57: 1320\u20131329","journal-title":"J Clin Invest"},{"key":"BFncpendmet0637_CR58","first-page":"12280","volume":"92","author":"U Kaiser","year":"1995","unstructured":"Kaiser U  et al. (1995) A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone. Physiology 92: 12280\u201312284","journal-title":"Physiology"},{"key":"BFncpendmet0637_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1210\/jcem-49-1-8","volume":"49","author":"J Hoff","year":"1979","unstructured":"Hoff J  et al. (1979) The functional relationship between priming and releasing actions of luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 49: 8\u201311","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR60","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/BF03350785","volume":"21","author":"J Hall","year":"1998","unstructured":"Hall J  et al. (1998) Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome. J Endocrinol Invest 21: 602\u2013611","journal-title":"J Endocrinol Invest"},{"key":"BFncpendmet0637_CR61","first-page":"582","volume":"83","author":"CL Pastor","year":"1998","unstructured":"Pastor CL  et al. (1998) Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 83: 582\u2013590","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR62","first-page":"4047","volume":"85","author":"CA Eagleson","year":"2000","unstructured":"Eagleson CA  et al. (2000) Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85: 4047\u20134052","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0637_CR63","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","volume":"108","author":"EY Adashi","year":"1981","unstructured":"Adashi EY  et al. (1981) Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108: 1441\u20131449","journal-title":"Endocrinology"},{"key":"BFncpendmet0637_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI113864","volume":"83","author":"A Dunaif","year":"1989","unstructured":"Dunaif A and Graf M (1989) Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest 83: 23\u201329","journal-title":"J Clin Invest"},{"key":"BFncpendmet0637_CR65","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1210\/jc.2004-1040","volume":"90","author":"RV Mehta","year":"2005","unstructured":"Mehta RV  et al. (2005) Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment. J Clin Endocrinol Metab 90: 2136\u20132141","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0637","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:54:17Z","timestamp":1684439657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BFncpendmet0637"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0637","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}